Enveric Biosciences Files Routine 8-K, Confirms Nasdaq Listing
Ticker: ENVB · Form: 8-K · Filed: Jan 3, 2024 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Jan 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, regulation-fd
TL;DR
**Enveric Biosciences filed a routine 8-K, no new material info for traders.**
AI Summary
Enveric Biosciences, Inc. filed an 8-K on January 3, 2024, primarily to disclose general company information and confirm its registration on The Nasdaq Stock Market under the trading symbol ENVB. This filing is largely administrative, updating basic corporate details like its address in Naples, FL, and its telephone number (239-302-1707). For investors, this filing is a routine update and doesn't signal any immediate operational or financial changes, meaning it has minimal direct impact on the stock's valuation or future prospects.
Why It Matters
This filing is a standard administrative update, confirming basic company information and its listing on Nasdaq. It does not contain new financial or operational news that would typically move the stock.
Risk Assessment
Risk Level: low — This 8-K is a standard administrative filing and does not introduce any new financial or operational risks.
Analyst Insight
A smart investor would note this as a routine administrative filing and understand it contains no new material information to influence investment decisions. No immediate action is warranted based on this specific 8-K.
Key Numbers
- $0.01 — par value per share (the par value of Enveric Biosciences' common stock)
- 001-38286 — Commission File Number (Enveric Biosciences' SEC Commission File Number)
Key Players & Entities
- Enveric Biosciences, Inc. (company) — the registrant filing the 8-K
- The Nasdaq Stock Market (company) — the exchange where Enveric Biosciences' common stock is registered
- ENVB (company) — the trading symbol for Enveric Biosciences' common stock
- Naples, FL (company) — the city and state of Enveric Biosciences' principal executive offices
- 239-302-1707 (dollar_amount) — Enveric Biosciences' telephone number
FAQ
What is the purpose of Enveric Biosciences, Inc.'s 8-K filing dated January 3, 2024?
The 8-K filing by Enveric Biosciences, Inc. on January 3, 2024, is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily serving as a Regulation FD Disclosure and providing information on Financial Statements and Exhibits. It updates basic company information and confirms its listing on Nasdaq.
What is the trading symbol and exchange for Enveric Biosciences, Inc.'s common stock?
Enveric Biosciences, Inc.'s common stock has the trading symbol ENVB and is registered on The Nasdaq Stock Market, as stated in the filing under 'Securities registered pursuant to Section 12(b) of the Act'.
What is the address and telephone number of Enveric Biosciences, Inc. as reported in this filing?
The principal executive offices of Enveric Biosciences, Inc. are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103. The registrant's telephone number is (239) 302-1707, according to the filing.
What is the par value of Enveric Biosciences, Inc.'s common stock?
The common stock of Enveric Biosciences, Inc. has a par value of $0.01 per share, as indicated in the 'Title of each class' section of the filing.
Does this 8-K filing contain any information about changes in the company's operations or financial performance?
No, this 8-K filing primarily contains administrative information such as the company's address, telephone number, and stock exchange listing. It does not disclose any changes in operations, financial performance, or other material events that would typically impact the company's business or financial condition.
Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-01-03 08:05:11
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-000193.txt ( ) — 237KB
- envb-20240103.xsd (EX-101.SCH) — 3KB
- envb-20240103_lab.xml (EX-101.LAB) — 33KB
- envb-20240103_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 3, 2024 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer